108 related articles for article (PubMed ID: 21116708)
1. Variation in genes coding for AMP-activated protein kinase (AMPK) and breast cancer risk in the European Prospective Investigation on Cancer (EPIC).
Campa D; Claus R; Dostal L; Stein A; Chang-Claude J; Meidtner K; Boeing H; Olsen A; Tjønneland A; Overvad K; Rodríguez L; Bonet C; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Allen NE; Trichopoulou A; Bamia C; Benetou V; Palli D; Agnoli C; Panico S; Tumino R; Sacerdote C; van Kranen H; Bas Bueno-de-Mesquita H; Peeters PH; van Gils CH; Lenner P; Sund M; Lund E; Gram IT; Rinaldi S; Chajes V; Romieu I; Engel P; Boutron-Ruault MC; Clavel-Chapelon F; Siddiq A; Riboli E; Canzian F; Kaaks R
Breast Cancer Res Treat; 2011 Jun; 127(3):761-7. PubMed ID: 21116708
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the liver kinase B1-AMP-activated protein kinase pathway genes and pancreatic cancer risk.
Xu X; Qian D; Liu H; Cruz D; Luo S; Walsh KM; Abbruzzese JL; Zhang X; Wei Q
Mol Carcinog; 2019 Aug; 58(8):1338-1348. PubMed ID: 30997723
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk.
Campa D; McKay J; Sinilnikova O; Hüsing A; Vogel U; Hansen RD; Overvad K; Witt PM; Clavel-Chapelon F; Boutron-Ruault MC; Chajes V; Rohrmann S; Chang-Claude J; Boeing H; Fisher E; Trichopoulou A; Trichopoulos D; Palli D; Villarini A; Sacerdote C; Mattiello A; Tumino R; Peeters PH; van Gils CH; Bas Bueno-de-Mesquita H; Lund E; Chirlaque MD; Sala N; Suarez LR; Barricarte A; Dorronsoro M; Sánchez MJ; Lenner P; Hallmans G; Tsilidis K; Bingham S; Khaw KT; Gallo V; Norat T; Riboli E; Rinaldi S; Lenoir G; Tavtigian SV; Canzian F; Kaaks R
Breast Cancer Res Treat; 2009 Dec; 118(3):565-74. PubMed ID: 19252981
[TBL] [Abstract][Full Text] [Related]
4. Haplotype structures and large-scale association testing of the 5' AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 [corrected] with type 2 diabetes.
Sun MW; Lee JY; de Bakker PI; Burtt NP; Almgren P; Råstam L; Tuomi T; Gaudet D; Daly MJ; Hirschhorn JN; Altshuler D; Groop L; Florez JC
Diabetes; 2006 Mar; 55(3):849-55. PubMed ID: 16505254
[TBL] [Abstract][Full Text] [Related]
5. Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
Campa D; Hüsing A; Chang-Claude J; Dostal L; Boeing H; Kröger J; Tjønneland A; Roswall N; Overvad K; Dahm CC; Rodríguez L; Sala N; Pérez MJ; Larrañaga N; Chirlaque MD; Ardanaz E; Khaw KT; Wareham N; Allen NE; Travis RC; Trichopoulou A; Naska A; Bamia C; Palli D; Sieri S; Tumino R; Sacerdote C; van Kranen HJ; Bas Bueno-de-Mesquita H; Stattin P; Johansson M; Chajes V; Rinaldi S; Romieu I; Siddiq A; Norat T; Riboli E; Kaaks R; Canzian F
Eur J Cancer; 2011 Feb; 47(3):420-7. PubMed ID: 20965718
[TBL] [Abstract][Full Text] [Related]
6. Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).
Campa D; Hüsing A; Stein A; Dostal L; Boeing H; Pischon T; Tjønneland A; Roswall N; Overvad K; Østergaard JN; Rodríguez L; Sala N; Sánchez MJ; Larrañaga N; Huerta JM; Barricarte A; Khaw KT; Wareham N; Travis RC; Allen NE; Lagiou P; Trichopoulou A; Trichopoulos D; Palli D; Sieri S; Tumino R; Sacerdote C; van Kranen H; Bueno-de-Mesquita HB; Hallmans G; Johansson M; Romieu I; Jenab M; Cox DG; Siddiq A; Riboli E; Canzian F; Kaaks R
PLoS One; 2011 Feb; 6(2):e16914. PubMed ID: 21373201
[TBL] [Abstract][Full Text] [Related]
7. Association of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma.
Hoffman AE; Demanelis K; Fu A; Zheng T; Zhu Y
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):736-44. PubMed ID: 23396962
[TBL] [Abstract][Full Text] [Related]
8. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A; Arbiser JL; Bonner MY; Saxena NK; Sharma D
Breast Cancer Res; 2012 Feb; 14(1):R35. PubMed ID: 22353783
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of genes coding for ghrelin and its receptor in relation to anthropometry, circulating levels of IGF-I and IGFBP-3, and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Dossus L; McKay JD; Canzian F; Wilkening S; Rinaldi S; Biessy C; Olsen A; Tjønneland A; Jakobsen MU; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Fournier A; Linseisen J; Lukanova A; Boeing H; Fisher E; Trichopoulou A; Georgila C; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Quirós JR; Sala N; Martínez-García C; Dorronsoro M; Chirlaque MD; Barricarte A; van Duijnhoven FJ; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Hallmans G; Lenner P; Bingham S; Khaw KT; Key TJ; Travis RC; Ferrari P; Jenab M; Riboli E; Kaaks R
Carcinogenesis; 2008 Jul; 29(7):1360-6. PubMed ID: 18375957
[TBL] [Abstract][Full Text] [Related]
10. Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain.
Souza RP; Tiwari AK; Chowdhury NI; Ceddia RB; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
J Psychiatr Res; 2012 Apr; 46(4):462-8. PubMed ID: 22305490
[TBL] [Abstract][Full Text] [Related]
11. Association study of AMP-activated protein kinase subunit genes in polycystic ovary syndrome.
Sproul K; Jones MR; Azziz R; Goodarzi MO
Eur J Endocrinol; 2009 Sep; 161(3):405-9. PubMed ID: 19574280
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer.
Lee SJ; Kang BW; Chae YS; Kim HJ; Park SY; Park JS; Choi GS; Jeon HS; Lee WK; Kim JG
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S634-9. PubMed ID: 24770722
[TBL] [Abstract][Full Text] [Related]
13. AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism.
Randrianarisoa E; Lehn-Stefan A; Krier J; Böhm A; Heni M; Hrabě De Angelis M; Fritsche A; Häring HU; Stefan N; Staiger H
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31512724
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer.
Chen M; Jiang B; He B; Tang M; Wang P; Chen L; Lu J; Lu P
BMC Cancer; 2018 Sep; 18(1):923. PubMed ID: 30253744
[TBL] [Abstract][Full Text] [Related]
15. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
Kim KY; Han W; Noh DY; Kang D; Kwack K
Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
[TBL] [Abstract][Full Text] [Related]
16. Differential crosstalk between the AMPK and PI3K/Akt pathways in breast cancer cells of differing genotypes: Leptin inhibits the effectiveness of AMPK activation.
El-Masry OS; Al-Sakkaf K; Brown BL; Dobson PR
Oncol Rep; 2015 Oct; 34(4):1675-80. PubMed ID: 26260992
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes.
Keshavarz P; Inoue H; Nakamura N; Yoshikawa T; Tanahashi T; Itakura M
Mol Genet Metab; 2008 Feb; 93(2):200-9. PubMed ID: 17950019
[TBL] [Abstract][Full Text] [Related]
18. The bovine 5' AMPK gene family: mapping and single nucleotide polymorphism detection.
McKay SD; White SN; Kata SR; Loan R; Womack JE
Mamm Genome; 2003 Dec; 14(12):853-8. PubMed ID: 14724738
[TBL] [Abstract][Full Text] [Related]
19. Anticancer properties of pomolic acid-induced AMP-activated protein kinase activation in MCF7 human breast cancer cells.
Youn SH; Lee JS; Lee MS; Cha EY; Thuong PT; Kim JR; Chang ES
Biol Pharm Bull; 2012; 35(1):105-10. PubMed ID: 22223345
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms and haplotypic diversity in the bovine PRKAB1 gene.
Zhang Q; Chen H; Zhao S; Zhang L; Zhang L; Li F; Wang X
Mol Biotechnol; 2009 Nov; 43(3):193-9. PubMed ID: 19578998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
